AAAAAA

   
Results: 1-14 |
Results: 14
Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition
Authors: Dechend, R Fiebler, A Lindschau, C Bischoff, H Muller, D Park, JK Dietz, R Haller, H Luft, FC
Citation: R. Dechend et al., Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition, AM J HYPERT, 14(6), 2001, pp. 55S-61S
Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organdamage
Authors: Muller, DN Heissmeyer, V Dechend, R Hampich, F Park, JK Fiebeler, A Shagdarsuren, E Theuer, J Elger, M Pilz, B Breu, V Schroer, K Ganten, D Dietz, R Haller, H Scheidereit, C Luft, FC
Citation: Dn. Muller et al., Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organdamage, FASEB J, 15(8), 2001, pp. NIL_117-NIL_135
Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-Induced cardiac injury
Authors: Fiebeler, A Schmidt, F Muller, DN Park, JK Dechend, R Bieringer, M Shagdarsuren, E Breu, V Haller, H Luft, FC
Citation: A. Fiebeler et al., Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-Induced cardiac injury, HYPERTENSIO, 37(2), 2001, pp. 787-793
Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
Authors: Dechend, R Fiebeler, A Park, JK Muller, DN Theuer, J Mervaala, E Bieringer, M Gulba, D Dietz, R Luft, FC Haller, H
Citation: R. Dechend et al., Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, CIRCULATION, 104(5), 2001, pp. 576-581
Synthesis of C-X-C and C-C chemokines by human peritoneal fibroblasts - Induction by macrophage-derived cytokines
Authors: Witowski, J Thiel, A Dechend, R Dunkel, K Fouquet, N Bender, TO Langrehr, JM Gahl, GM Frei, U Jorres, A
Citation: J. Witowski et al., Synthesis of C-X-C and C-C chemokines by human peritoneal fibroblasts - Induction by macrophage-derived cytokines, AM J PATH, 158(4), 2001, pp. 1441-1450
Effect of bosentan on NF-kappa B, inflammation, and tissue factor in angiotensin II-induced end-organ damage
Authors: Muller, DN Mervaala, EMA Schmidt, F Park, JK Dechend, R Genersch, E Breu, V Loffler, BM Ganten, D Schneider, W Haller, H Luft, FC
Citation: Dn. Muller et al., Effect of bosentan on NF-kappa B, inflammation, and tissue factor in angiotensin II-induced end-organ damage, HYPERTENSIO, 36(2), 2000, pp. 282-290
NF-kappa B inhibition ameliorates angiotensin II-induced inflammatory damage in rats
Authors: Muller, DN Dechend, R Mervaala, EMA Park, JK Schmidt, F Fiebeler, A Theuer, J Breu, V Ganten, D Haller, H Luft, FC
Citation: Dn. Muller et al., NF-kappa B inhibition ameliorates angiotensin II-induced inflammatory damage in rats, HYPERTENSIO, 35(1), 2000, pp. 193-201
Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes
Authors: Mervaala, E Muller, DN Park, JK Dechend, R Schmidt, F Fiebeler, A Bieringer, M Breu, V Ganten, D Haller, H Luft, FC
Citation: E. Mervaala et al., Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes, HYPERTENSIO, 35(1), 2000, pp. 360-366
Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects
Authors: Park, JK Muller, DN Mervaala, EMA Dechend, R Fiebeler, A Schmidt, F Bieringer, M Schafer, O Lindschau, C Schneider, W Ganten, D Luft, FC Haller, H
Citation: Jk. Park et al., Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects, KIDNEY INT, 58(4), 2000, pp. 1420-1430
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor
Authors: Dechend, R Homuth, V Wallukat, G Kreuzer, J Park, JK Theuer, J Juepner, A Gulba, DC Mackman, N Haller, H Luft, FC
Citation: R. Dechend et al., AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor, CIRCULATION, 101(20), 2000, pp. 2382-2387
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor inangiotensin II-induced cardiac vasculopathy
Authors: Muller, DN Mervaala, EMA Dechend, R Fiebeler, A Park, JK Schmidt, F Theuer, J Breu, V Mackman, N Luther, T Schneider, W Gulba, D Ganten, D Haller, H Luft, FC
Citation: Dn. Muller et al., Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor inangiotensin II-induced cardiac vasculopathy, AM J PATH, 157(1), 2000, pp. 111-122
The Bcl-3 oncoprotein acts as a bridging factor between NF-kappa B/Rel andnuclear co-regulators
Authors: Dechend, R Hirano, F Lehmann, K Heissmeyer, V Ansieau, S Wulczyn, FG Scheidereit, C Leutz, A
Citation: R. Dechend et al., The Bcl-3 oncoprotein acts as a bridging factor between NF-kappa B/Rel andnuclear co-regulators, ONCOGENE, 18(22), 1999, pp. 3316-3323
Hypertension-induced end-organ damage - A new transgenic approach to an old problem
Authors: Luft, FC Mervaala, E Muller, DN Gross, V Schmidt, F Park, JK Schmitz, C Lippoldt, A Breu, V Dechend, R Dragun, D Schneider, W Ganten, D Haller, H
Citation: Fc. Luft et al., Hypertension-induced end-organ damage - A new transgenic approach to an old problem, HYPERTENSIO, 33(1), 1999, pp. 212-218
Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappa B and induces tissue factor and PAI-1 expression - A potential link to accelerated arteriosclerosis
Authors: Dechend, R Maass, M Gieffers, J Dietz, R Scheidereit, C Leutz, A Gulba, DC
Citation: R. Dechend et al., Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappa B and induces tissue factor and PAI-1 expression - A potential link to accelerated arteriosclerosis, CIRCULATION, 100(13), 1999, pp. 1369-1373
Risultati: 1-14 |